Department of Urology, Seoul National University Bundang Hospital, 300, Gumi-dong, Bundang-gu, Seongnam-si, Kyunggi-do, 463-707, Korea.
Department of Urology, Seoul National University College of Medicine, Seoul, Korea.
J Cancer Res Clin Oncol. 2019 Nov;145(11):2863-2870. doi: 10.1007/s00432-019-03020-z. Epub 2019 Sep 9.
To determine the association between lymphovascular invasion (LVI) and upper tract urothelial carcinoma (UTUC) among patients who underwent radical nephroureterectomy (RNU).
From 2003 and 2018, retrospective data of 453 patients treated for UTUC with open, laparoscopic, or robotic RNU were collected. Pathological specimens were assessed for LVI through hematoxylin and eosin staining. According to presence of LVI, patients were stratified into two groups and compared for perioperative characteristics. Kaplan-Meier analysis was used to assess progression-free (PFS), cancer-specific (CSS), and overall survival (OS). Uni- and multivariate Cox regression models were used to find significance of LVI to survival.
LVI was present in 132 (29.1%) of patients and was associated with higher age and lower preoperative GFR. Pathological outcomes included significantly higher tumor grade, higher rates of lymph node invasion and more positive surgical margins. During median 23.2 months follow-up (mean 37.1 months), 59.2% (n = 268) of total patients had tumor recurrence, with highest incidences in lymph nodes (51.5%). 5-year PFS, CSS, and OS were estimated at 35.4%, 94.6%, and 91.1% in LVI-negative patients and 17.2%, 75.1%, and 70.8% in LVI-positive patients, respectively (all p < 0.001). Multivariate analysis showed LVI to be an independent predictor of PFS (HR = 1.480; p = 0.018).
LVI is an independent predictor of adverse PFS and is associated with poor CSS and OS in patients undergoing RNU for UTUC. These results may guide clinicians in selecting patients for adjuvant chemotherapy. Future prospective trials are necessary to further validate our results.
确定接受根治性肾输尿管切除术(RNU)的患者中淋巴血管侵犯(LVI)与上尿路上皮癌(UTUC)之间的关联。
从 2003 年至 2018 年,收集了 453 例接受开放、腹腔镜或机器人 RNU 治疗的 UTUC 患者的回顾性数据。通过苏木精和伊红染色评估病理标本中的 LVI。根据 LVI 的存在,患者被分为两组,并对围手术期特征进行比较。Kaplan-Meier 分析用于评估无进展生存期(PFS)、癌症特异性生存期(CSS)和总生存期(OS)。单变量和多变量 Cox 回归模型用于发现 LVI 对生存的意义。
132 例(29.1%)患者存在 LVI,且 LVI 与较高的年龄和较低的术前肾小球滤过率相关。病理结果包括肿瘤分级显著升高、淋巴结侵犯率较高和更多的阳性手术切缘。在中位 23.2 个月(平均 37.1 个月)的随访期间,59.2%(n=268)的患者发生肿瘤复发,淋巴结的发生率最高(51.5%)。在 LVI 阴性患者中,5 年 PFS、CSS 和 OS 估计值分别为 35.4%、94.6%和 91.1%,而在 LVI 阳性患者中,这三个值分别为 17.2%、75.1%和 70.8%(均 p<0.001)。多变量分析表明,LVI 是 PFS 的独立预测因子(HR=1.480;p=0.018)。
LVI 是 PFS 的独立预测因子,与接受 RNU 治疗的 UTUC 患者的 CSS 和 OS 不良相关。这些结果可能有助于指导临床医生选择接受辅助化疗的患者。未来需要前瞻性试验进一步验证我们的结果。